Envoy Medical Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,114.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +65.5% | -29.2% | +23.5% | +16.7% | -2.0% | +27.1% | +39.3% | -10.6% | +5.3% | -8.8% | +1.4% | – | |
| – | – | -92.2% | +15.4% | +1.4% | +6.3% | +4.6% | -8.8% | +121.9% | -119.8% | – | +559.1% | – | |
| – | -244.5% | – | – | +407.9% | -187.2% | – | -91.6% | +889.6% | -89.8% | -1,071.8% | – | – | |
| – | -66.1% | +419.0% | +624.8% | -22.2% | -13.2% | -98.9% | -83.3% | -100.0% | – | -100.0% | – | – | |
| – | -66.1% | +419.0% | +624.8% | -22.2% | – | -101.1% | -83.3% | – | – | – | – | – | |
| – | – | – | – | – | -66.5% | +97.6% | -50.0% | -100.0% | – | +134,900.0% | -4.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -44.2% | +16.7% | -0.1% | -105.6% | -65.9% | +128.6% | +2.4% | – | |
| – | -109.2% | – | -66.5% | +172.6% | -19.5% | -27.7% | +24.9% | -41.4% | +132.2% | +356.5% | -100.4% | – | |
| – | -175.3% | – | -540.0% | – | -60.5% | -116.1% | – | – | – | +11,655.2% | -125.9% | – | |
| – | -1,176.8% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.